Benedetto Maurizio Celesia

26PUBLICATIONS
56CO-AUTHORS
Behavioural epidemiologyInnate immunityPharmaceutical delivery technologiesFeminist theoryInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 23, 2026
Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People with HIV: Real-World Evidence from the SHINe-SHIC Cohort.

|Mar 28, 2026
The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count Nadir.

Manuela Ceccarelli, Elena Delfina Ricci, Camilla Muccini

|Nov 27, 2025
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World Study.

Giuseppe Nicolò Conti, Serena Spampinato, Andrea De Vito

|Jul 30, 2025
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation.

Serena Spampinato, Emmanuele Venanzi Rullo, Giuseppe Nicolò Conti

|Jul 25, 2025
Dirofilaria repens in the Spermatic Cord of a 5-Year-Old Boy: A Rare Pediatric Case in Italy.

Alessandro Franzò, Andrea Marino, Benedetto Maurizio Celesia

|Oct 26, 2024
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.

Agnese Colpani, Andrea De Vito, Andrea Marino

Pageof 5

Frequent Collaborators

14 joint publications

Andrea Marino

12 joint publications

Giovanni Francesco Pellicanò

11 joint publications

Giuseppe Nunnari

9 joint publications

Giordano Madeddu